Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
03/2012
03/13/2012CA2502358C Methods for purifying radiolabelled compounds
03/13/2012CA2419607C Peptidomimetic protease inhibitors
03/13/2012CA2365898C Ibd-associated microbial antigens and methods of using same
03/13/2012CA2330492C Novel octahydro-6,10-dioxo-6h-pyridazino/1,2-a/ /1,2/diazepin-1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds
03/08/2012WO2012031250A2 Compositions for labeling nerves and methods of use
03/08/2012WO2012030217A2 Culture medium for eukaryotic cells
03/08/2012WO2011123179A3 Alkylated sp-c peptoid compounds and related surfactant compositions
03/08/2012US20120058958 Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell
03/08/2012US20120058957 Compositions and methods for counteracting effects of reactive oxygen species and free radicals
03/08/2012US20120058953 Compositions and methods for enhancing apoptosis
03/08/2012US20120058945 Neuroprotective iron chelators and pharmaceutical compositions comprising them
03/08/2012US20120058937 Prodrugs of Neuraminidase Inhibitors
03/08/2012US20120058932 Active ingredient-peptide construct for extracellular concentration
03/08/2012US20120058905 DNA Sequences Encoding Caryophyllaceae and Caryophyllaceae-Like Cyclopeptide Precursors and Methods of Use
03/08/2012US20120055781 Microwave-assisted peptide synthesis
03/08/2012CA2807895A1 Culture medium for eukaryotic cells
03/07/2012CN101735306B Anti-inflammatory peptide with membrane penetration effect
03/06/2012US8129561 Processes for intermediates for macrocyclic compounds
03/06/2012US8129407 Hemiasterlin derivatives and uses thereof in the treatment of cancer
03/06/2012US8129346 Compounds for enzyme inhibition
03/06/2012US8129342 High purity lipopeptides
03/06/2012US8129332 Reagents and methods for smooth muscle therapies
03/06/2012CA2202408C Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
03/01/2012US20120052094 Agonists of Neurotrophin Receptors and Their Use as Medicaments
03/01/2012DE102010036261A1 New peptide having a length of two to five monomers, where the monomers are an alpha hydroxy-4(1H)-pyridinone compounds, useful to treat metal (preferably iron, copper or aluminum) storage disorders, preferably siderosis
02/2012
02/29/2012EP2421886A2 Peptide compositions
02/29/2012EP2421885A1 Bleaching peptide hydrolysate proteasome activator and compositions containing same
02/29/2012EP2421884A1 Peptide hydrolysate proteasome activators and compositions containing same
02/29/2012EP2421883A1 Trapping compounds and method for identifying reactive metabolites
02/29/2012CN102365294A Dipeptide mimetics of ngf and bdnf neurotrophins
02/29/2012CN101921313B Polypeptide for curing or preventing cancer or derivative product and application thereof
02/29/2012CN101267830B Growth hormone secretagogues
02/28/2012US8124725 PDGF-Rβ binders
02/28/2012US8124584 Macrocyclic hepatitis C serine protease inhibitors
02/23/2012WO2010146172A3 New synthetic route for the preparation of alpha-amino boronic esters
02/23/2012US20120046591 Treatment devices and methods with extending elements
02/23/2012US20120046586 Skin treatment devices and methods with pre-stressed configurations
02/23/2012US20120046445 Glutathione-based delivery system
02/23/2012US20120046441 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
02/23/2012US20120045474 Substrate peptide sequences for plague plasminogen activator and uses thereof
02/23/2012US20120045394 Human and mouse targeting peptides identified by phage display
02/22/2012EP2419439A1 Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolysate
02/22/2012EP2419438A1 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolysate that can reinforce the barrier function
02/22/2012EP2419437A1 Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions
02/22/2012EP2086995B1 Hepatitis c virus inhibitors
02/21/2012US8119631 Inhibitors of interleukin-1β converting enzyme
02/21/2012US8119590 Apolipoprotein A-I (ApoA-I), preferably a variant form such as Apolipoprotein A-I Milano (ApoA-IM), alone or more preferably in combination with a lipid carrier such as phospholipids or other drug, can be administered locally
02/16/2012WO2012020364A1 Di peptide derivative for the treatment of cancer
02/16/2012WO2012019299A1 Hepatitis c inhibitor compounds
02/16/2012WO2005110456A8 T-cell death-inducing epitopes
02/16/2012US20120040912 Proteasome-activating anti-aging peptides and compositions containing same
02/15/2012EP2417151A1 Cyclic peptides with an anti-parasitic activity
02/15/2012EP2417108A1 Organic compounds and their uses
02/14/2012US8114830 Polypeptoid pulmonary surfactants
02/14/2012US8114439 Synthetic peptides reducing or removing bags formed under the lower eye contour and their use in cosmetic or dermopharmaceutical compositions
02/14/2012US8114431 Biomolecular coating for implants
02/09/2012WO2012019160A1 Dipeptides to enhance yield and viability from cell cultures
02/09/2012US20120035345 Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides
02/09/2012US20120035108 Spray base material including low-molecular gelator
02/09/2012US20120034593 Cyclic peptides with an anti-parasitic activity
02/09/2012US20120034364 Use of peptides for imparting kokumi
02/09/2012US20120034187 Hepatitis C Inhibitor Compounds
02/09/2012US20120031423 Bleaching composition
02/09/2012CA2807511A1 Processes for preparing tubulysins
02/08/2012EP2414382A2 Novel proteasome-activating lightening peptides and compositions containing same
02/08/2012EP2414381A2 Proteasome-activating anti-aging peptides and compositions containing same
02/08/2012EP2413891A2 Novel proteasome-activating anti-aging peptides and compositions containing same
02/08/2012EP1682074B1 Compositions and methods for healthy pregnancy
02/08/2012CN101060854B 具有抗糖尿病作用的蛋白质水解物 Protein hydrolysates have anti-diabetic action
02/07/2012US8110658 Peptide fragments for inducing synthesis of extracellular matrix proteins
02/07/2012US8110654 T cell epitope peptides of ovarian cancer anti-idiotypic antibody 6B11 and use thereof
02/07/2012US8110402 Metal abstraction peptide (MAP) tag and associated methods
02/07/2012CA2524222C N.epsilon. and/or n.alpha. derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3(co)3]+ by fac coordination
02/02/2012WO2012013136A1 Polypeptidic tyrosinase inhibitor
02/02/2012WO2012012843A1 Modulators of protease activated receptors
02/02/2012US20120028894 Peptides, pharmaceutical compositions comprising same and uses thereof
02/02/2012US20120028888 Apj receptor compounds
02/02/2012US20120028880 Vegfr-1/nrp-1 targeting peptides
02/02/2012US20120027703 Novel proteasome-activating anti-aging peptides and compositions containing same
02/02/2012US20120027677 Prion-specific peptoid reagents
02/01/2012EP2412720A2 Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides
02/01/2012EP2088152B1 N'-{n-[3-oxo-lupen-28-oyl]-9-aminononanoyl}-3-amino-3-phenylpropeonic acid and the pharmaceutically acceptable derivatives thereof, a method for the production and the use thereof in the form of a medicinal agent
02/01/2012EP1286989B1 Prodrug of an ICE inhibitor
02/01/2012CN102337318A Gingko antioxidant active peptide and preparation method thereof
02/01/2012CN102336807A Industrialization preparation method for RDG peptide
02/01/2012CN101602792B 一种新型抗菌脂肽及其制备和应用 A novel antibacterial lipopeptide its preparation and application
02/01/2012CN101153053B 骨生肽、其制备方法和其药物组合物与用途 Bone peptides, their preparation and pharmaceutical compositions and uses thereof
01/2012
01/31/2012US8106158 Compositions and methods for fusion protein separation
01/31/2012US8106020 Calcium receptor activator
01/31/2012US8106006 Modified defensins and their use
01/31/2012CA2393682C Depsipeptide and congeners thereof for use as immunosuppressants
01/26/2012WO2012010287A1 Tubulysin analogues
01/26/2012US20120022371 Compositions and methods for detecting and treating tumors containing acidic areas
01/26/2012US20120022004 Treatment of t-cell mediated diseases
01/26/2012US20120021970 Methods for preventing or treating mitochondrial permeability transition
01/26/2012US20120021530 HETEROGENEOUS FOLDAMERS CONTAINING alpha, beta, and/or gamma-AMINO ACIDS
01/26/2012US20120021454 Rapid fret-based diagnosis of bacterial pathogens
01/26/2012US20120021430 Functional lipid constructs
01/26/2012US20120021029 Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions
01/26/2012US20120020964 Antibodies for Norovirus
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 307